Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept in PAH with Unrepaired Congenital Shunts (SuMILE)
NCT07356778Phase 4Recruiting
- Start
- Oct 2025
- Primary completion
- Aug 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of sotatercept in pulmonary arterial hypertension (PAH). Started Oct 2025; status: recruiting.
02
Drugs
sotatercept
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT07356778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07356778.